Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for treatment of hospital delirium in older inpatients
ACTRN12619000034134Phase 3Active, not recruiting
- Sponsor
- Royal Melbourne Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Melatonin with Placebo (2 arms). Primary endpoint: Symptoms of delirium during treatment. Started Mar 2021; status: active, not recruiting.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12619000034134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000034134.